Drug Pricing Policy

Trump has used executive power and direct negotiations with pharmaceutical manufacturers to reshape drug pricing, delivering politically visible price cuts while binding companies to broad MFN commitments in exchange for favorable regulatory and market access conditions.

Ranked by appearances across this topic's actions.

• 
  Donald Trump

  Signed and issued the Executive Order directing the administration to pursue most-favored-nation drug pricing.
  1 action

Ranked by appearances across this topic's actions.

• Eli Lilly

  Announced at least $27 billion in new U.S. manufacturing investments, coinciding with the drug pricing agreement with the Trump administration.
  1 action

Derived from the organizations and individuals involved.

• Consumer Goods & Hospitality
• Cryptocurrency
• Defense & Aerospace
• Energy & Environment
• Federal Government
• Financial Services
• Media & Entertainment
• Pharmaceuticals & Healthcare
• Political Committees & Political Money
• Private Foundations & Donor Networks
• Technology & AI
• Telecommunications
• Trump Family Business